Brand Name: COSOVIR-D
Generic Name: Daclatasvir Dihydrochloride Tablets
Available Strengths:
Daclatasvir Dihydrochloride Tablets 60mg
Daclatasvir Dihydrochloride Tablets are highly effective antiviral medicines used in combination therapy for the treatment of chronic hepatitis C virus (HCV) infection. Daclatasvir is a direct-acting antiviral (DAA) and functions as an NS5A inhibitor, blocking viral RNA replication and assembly to achieve sustained virologic response (SVR). It is commonly prescribed along with Sofosbuvir or other antivirals, depending on the HCV genotype. This combination helps reduce viral load rapidly and prevents liver-related complications, including fibrosis, cirrhosis, and hepatocellular carcinoma. The medicine should be taken strictly under the guidance of a healthcare professional, with regular monitoring to ensure safety and effectiveness.
Capabilities Offered:
Ready dossier for both strengths in CTD/ ACTD format
Third party manufacturing services
Contract Manufacturing (CMO Services)
Formulation Development Services
Regulatory & Documentation Support
Export / Licensing Services
In addition to the products listed on our website, we possess the technical capability and infrastructure to develop and manufacture customized formulations as per your specific requirements and regulatory markets.
For business inquiries, email at sales@cooperpharma.com